Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avanos Medical Inc (AVNS)

Avanos Medical Inc (AVNS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Here's Why You Should Retain Avanos Medical Stock for Now

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

SRDX : 39.49 (+3.98%)
MMSI : 42.19 (-0.61%)
OPK : 3.17 (+1.28%)
AVNS : 33.85 (+1.59%)
Avanos Medical, Inc. Appoints Michelle Scharfenberg as Senior Vice President & Chief Ethics and Compliance Officer

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that has been named as the company's senior vice president & chief ethics and compliance officer.

AVNS : 33.85 (+1.59%)
Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in September

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in September:

AVNS : 33.85 (+1.59%)
Avanos Medical, Inc. Announces Publication of Clinical Trial Demonstrating Superiority of COOLIEF* over Hyaluronic Acid Injections for the Management of Chronic Knee Pain

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the publication of a large, randomized, multicentered clinical trial comparing the safety and efficacy of COOLIEF* Cooled Radiofrequency...

AVNS : 33.85 (+1.59%)
Avanos Medical, Inc. Appoints Bill Haydon as Senior Vice President & General Manager, Pain Franchise

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that has been appointed senior vice president & general manager for the company's newly combined pain franchise. In this role, Haydon...

AVNS : 33.85 (+1.59%)
Avanos Medical (AVNS) Q2 Earnings and Revenues Top Estimates

Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.

PKI : 118.20 (-1.08%)
TMO : 429.05 (-0.90%)
WST : 277.73 (+1.01%)
AVNS : 33.85 (+1.59%)
Avanos Medical (AVNS) Q2 Earnings and Revenues Surpass Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 33.85 (+1.59%)
Avanos Medical, Inc. Announces Second Quarter 2020 Results

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2020 financial results.

AVNS : 33.85 (+1.59%)
Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AVNS : 33.85 (+1.59%)
Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in June

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June:

AVNS : 33.85 (+1.59%)
Here's Why You Should Retain Avanos Medical Stock for Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.

HMSY : 25.40 (-1.17%)
WST : 277.73 (+1.01%)
AVNS : 33.85 (+1.59%)
APHA : 4.68 (+0.43%)
Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top

Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.

BIIB : 274.48 (-0.32%)
LLY : 154.17 (+1.11%)
AVNS : 33.85 (+1.59%)
APHA : 4.68 (+0.43%)
Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 33.85 (+1.59%)
Avanos Medical, Inc. Announces First Quarter 2020 Results and Provides an Update on its Response to the COVID-19 Pandemic

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic.

AVNS : 33.85 (+1.59%)
Here's Why You Should Hold on to Avanos Medical Stock Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

MCK : 152.13 (+0.42%)
MMSI : 42.19 (-0.61%)
COO : 346.43 (-0.39%)
AVNS : 33.85 (+1.59%)
Why Is Avanos Medical (AVNS) Down 30.2% Since Last Earnings Report?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AVNS : 33.85 (+1.59%)
Here's Why You Should Hold Avanos Medical (AVNS) Stock Now

Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.

SYK : 206.38 (-2.45%)
ARAY : 2.65 (+12.77%)
IDXX : 354.76 (+0.16%)
AVNS : 33.85 (+1.59%)
Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4

Avanos (AVNS) gains from segmental contributions in Q4.

SYK : 206.38 (-2.45%)
ARAY : 2.65 (+12.77%)
IDXX : 354.76 (+0.16%)
AVNS : 33.85 (+1.59%)
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 33.85 (+1.59%)
New Strong Sell Stocks for January 14th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

BOOM : 34.80 (+2.75%)
DK : 11.88 (-1.90%)
DLTR : 88.02 (-0.59%)
ELAN : 26.54 (-2.96%)
AVNS : 33.85 (+1.59%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar